您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Ciprofloxacin hydrochloride monohydrate
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Ciprofloxacin hydrochloride monohydrate
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Ciprofloxacin hydrochloride monohydrate图片
CAS NO:86393-32-0
包装与价格:
包装价格(元)
500mg电议
1 g电议
5 g电议
10 g电议
50 g电议

产品名称
环丙沙星盐酸盐一水合物
Bay-09867 hydrochloride monohydrate
产品介绍
Ciprofloxacin (Bay-09867) hydrochloride monohydrate 是一种口服有效的拓扑异构酶 IV 抑制剂。Ciprofloxacin hydrochloride monohydrate 诱导线粒体 DNA 和核 DNA 损伤并导致线粒体功能障碍和活性氧产生。Ciprofloxacin hydrochloride monohydrate 具有抗增殖活性并诱导细胞凋亡 (apoptosis)。Ciprofloxacin hydrochloride monohydrate 是一种氟喹诺酮类抗生素,具有强大的抗菌活性。
生物活性

Ciprofloxacin (Bay-09867) hydrochloride monohydrate is a potent, orally activetopoisomeraseIVinhibitor. Ciprofloxacin hydrochloride monohydrate induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin hydrochloride monohydrate has anti-proliferative activity and inducesapoptosis. Ciprofloxacin hydrochloride monohydrate is a fluoroquinoloneantibiotic, exhibiting potentantibacterialactivity[1][2][3][4].

IC50& Target

Quinolone

 

体外研究
(In Vitro)

Ciprofloxacin (Bay-09867) hydrochloride monohydrate (5-50 μg/mL; 0-24 h; tendon cells) inhibits cell proliferation and causes cell cycle arrest at the G2/M phase[1].
Ciprofloxacin (Bay-09867) hydrochloride monohydrate shows potent activity againstY. pestisandB. anthraciswith MIC90of 0.03 μg/mL and 0.12 μg/mL, respectively[2].

Cell Viability Assay[1]

Cell Line:Tendon cells
Concentration:5, 10, 20 and 50 μg/mL
Incubation Time:24 hours
Result:Decreased the cellularity of tendon cells.

Cell Cycle Analysis[1]

Cell Line:Tendon cells
Concentration:50 μg/mL
Incubation Time:24 hours
Result:Arrested cell cycle at the G2/M phase and inhibited cell division in tendon cells.

Western Blot Analysis[1]

Cell Line:Tendon cells
Concentration:50 μg/mL
Incubation Time:0, 6, 12, 17 and 24 hours
Result:Down-regulated the expression of CDK-1 and cyclin B protein and mRNA. Up-regulated the expression of PLK-1 protein.
体内研究
(In Vivo)

Ciprofloxacin (Bay-09867) hydrochloride monohydrate (30 mg/kg; i.p.; for 24 hours; BALB/c mice) has protection againstY. pestisin murine model of pneumonic plague[3].
Ciprofloxacin (Bay-09867) hydrochloride monohydrate (100 mg/kg; i.g.; daily, for 4 weeks; C57BL/6J mice) accelerates aortic root enlargement and increases the incidence of aortic dissection and rupture by decreases LOX level and increases MMP levels and activity in the aortic wall[4].
Ciprofloxacin (Bay-09867) hydrochloride monohydrate (100 mg/kg; i.g.; daily, for 4 weeks; C57BL/6J mice) induces DNA damage and release of DNA to the cytosol, mitochondrial dysfunction, and activation of cytosolic DNA sensor signaling. Ciprofloxacin lactate increases apoptosis and necroptosis in the aortic wall[4].

Animal Model:BALB/c mice[3]
Dosage:30 mg/kg
Administration:Intraperitoneal injection; for 24 hours
Result:Reduced the lung bacterial load in murine model of pneumonic plague.
Animal Model:C57BL/6J mice[4]
Dosage:100 mg/kg
Administration:Oral gavage; daily, for 4 weeks
Result:Had aortic destruction that was accompanied by decreased LOX expression and increased MMP expression and activity.
Animal Model:C57BL/6J mice[4]
Dosage:100 mg/kg
Administration:Oral gavage; daily, for 4 weeks
Result:Caused mitochondrial DNA and nuclear DNA damage, leading to mitochondrial dysfunction and ROS production. Increased apoptosis and necroptosis in the aortic wall.
Clinical Trial
分子量

385.82

性状

Solid

Formula

C17H21ClFN3O4

CAS 号

86393-32-0

中文名称

环丙沙星盐酸盐一水合物

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据
In Vitro: 

DMSO : 5 mg/mL(12.96 mM;ultrasonic and warming and heat to 60℃)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM2.5919 mL12.9594 mL25.9188 mL
5 mM0.5184 mL2.5919 mL5.1838 mL
10 mM0.2592 mL1.2959 mL2.5919 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO    40%PEG300   5%Tween-80   45% saline

    Solubility: ≥ 0.5 mg/mL (1.30 mM); Clear solution

    此方案可获得 ≥ 0.5 mg/mL (1.30 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 5.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH2O 中,得到澄清透明的生理盐水溶液
  • 2.

    请依序添加每种溶剂: 10% DMSO    90% (20%SBE-β-CDin saline)

    Solubility: ≥ 0.5 mg/mL (1.30 mM); Clear solution

    此方案可获得 ≥ 0.5 mg/mL (1.30 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 5.0 mg/mL 的澄清 DMSO 储备液加到 900 μL20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。

    将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中,再用生理盐水定容至 10 mL,完全溶解,澄清透明
  • 3.

    请依序添加每种溶剂: 10% DMSO    90%corn oil

    Solubility: ≥ 0.5 mg/mL (1.30 mM); Clear solution

    此方案可获得 ≥ 0.5 mg/mL (1.30 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 5.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

*以上所有助溶剂都可在本网站选购。